RESI Early Stage Medtech Investor Panel Announced

13 Nov

By Tom Crosby, RESI Conference Manager, LSN

Tom 2Last week, LSN announced the RESI Conference’s new Commercializing Medtech Innovation panel, which will bring insights from investors who focus on devices that are nearing commercialization. This week, LSN is proud to announce another brand new panel in the Medtech Investor Panels track — this time, featuring investors who focus on earlier-stage opportunities. The In Development / Clinical Investors Medtech panel will offer viewpoints and advice from a diverse group of investors.

Moderated by Vicki Anastasi, Vice President & Global Head of Medical Device and Diagnostic Research at ICON, the audience will hear from:

Cary Adams, Founder, Almond Tree Capital

Jeff Sheldon, Managing Director, CitareTX

Ibraheem Badejo, Senior Director, New Ventures, Johnson & Johnson Innovation

Doug Fisher, Partner, InterWest Partners

Panelists will share their opinions on why medical device investments have been surging in 2014, and how entrepreneurs can capitalize on the trend. What is the path of least resistance from prototype to allocation? How do device entrepreneurs identify and qualify organizations that are actively investing early? What are the pros and cons of taking a venture capital investment, and what are the roles of other sources of funding? With a panel drawn from a wide variety of backgrounds, the session will offer an interesting perspective for any device company looking to take its technology to the next level.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: